Abstract
The relationship between diabetes mellitus and risk of inappropriate or appropriate therapy in patients receiving an implantable cardioverter-defibrillator (ICD) and resynchronization therapy has not been investigated thoroughly. The effect of innovative ICD programming on therapy delivery in these patients is unknown.
| Original language | English |
|---|---|
| Journal | Circulation (Baltimore) |
| Volume | 128 |
| Issue number | 7 |
| Pages (from-to) | 694-701 |
| Number of pages | 8 |
| ISSN | 0009-7322 |
| DOIs | |
| Publication status | Published - 13 Aug 2013 |
Keywords
- Aged
- Algorithms
- Arrhythmias, Cardiac
- Cardiac Resynchronization Therapy
- Cardiac Resynchronization Therapy Devices
- Defibrillators, Implantable
- Diabetes Complications
- Electric Countershock
- Equipment Failure
- Female
- Follow-Up Studies
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Models, Cardiovascular
- Proportional Hazards Models
- Risk
- Single-Blind Method
- Tachycardia, Ventricular
- Unnecessary Procedures
Fingerprint
Dive into the research topics of 'Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS